Aicuris Gmbh + Co. Kg.

Bayer Aktiengesellschaft

Bayer Intellectual Property Gmbh

Bayer Schering Pharma Ag

Bayer Healthcare Aktiengesellschaft

Martin Radtke

Kerstin Henninger

Holger Zimmermann

Dieter Lang

Martin Hendrix

Armin Kern

David Brueckner

Johannes-Peter Stasch

Ulrich Rosentreter

Siegfried Raddatz

Gunter Schmidt

Jörg Keldenich

Joachim Mittendorf

Tobias Wunberg

Raimund Kast

Joerg Keldenich

Hartmut Schirok

Wolfgang Bender

Klaus Münter

Peter Eckenberg

Samir Bennabi

Jürgen Reefschläger

Michael Thutewohl

Sabine Hallenberger

Heimo Ehmke

Franz Zumpe

Hilmar Bischoff

Peter Fey

Delf Schmidt

Rolf Angerbauer

Mark Jean Gnoth

Daniela Paulsen

Dirk Heimbach

Guy Hewlett

Santiago Figueroa Perez

Wolfgang Kanhai

Wolfgang Karl

David Brückner

Santiago Figureoa Perez

Marc Jean Gnoth

The invention relates to heterocyclylamide-substituted thiazoles, pyrroles and thiophenes and processes for their preparation, to pharmaceutical compositions containing them, and to their use for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.

Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes

The invention relates to hetaryloxy-substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.

Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors

The invention relates to heterocyclylamide-substituted imidazoles and methods for their preparation, their use for the treatment and/or prophylaxis of diseases as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.

Heterocyclyamide-substituted imidazoles

The invention relates to the substituted imidazoles of formula (I) and to methods for producing the same, to their use in the treatment and/or prophylaxis of diseases and to their use for producing drugs for use in the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, especially against cytomegaloviruses.

Antiviral 4-aminocarbonylamino-substituted imidazole compounds

The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.

Substituted phenylamino-pyrimidines

The present invention relates to novel sulphonamides of the general formula (I) in which the substituents R, R, R, Rand A and X are as defined in claimand other claims, and also to processes for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.

Arylsulfonamides as antiviral agents

The invention relates to novel sulfonamides of general formula (I) where the substituents R, R, R, R, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.

Hetrocyclic aryl sulphonamides

The 6-(hydroxymethyl-ethyl)pyridines are prepared by a process in which the 3-hydroxymethylpyridines which are hydroxyl-protected in the 6-position are oxidized to the 3-aldehyde, this is then converted into the corresponding oxoheptenoic acid derivative using a Wittig-Homer reaction, after this the oxo group is reduced to the hydroxyl group and then the isomers are separated by chromatography. The 6-(hydroxymethyl-ethyl)pyridines are suitable as active compounds in medicaments, in particular in medicaments having antiarteriosclerotic activity.

6-(hydroxymethyl-ethyl)pyridines

Growing community of inventors

Erkrath, Germany

Martin Radtke